Nucleic acid molecules comprising the promoter for PCA3dd3, a new prostate antigen, and uses thereof
AssigneeUniversity Hospital Nijmegen
InventorsMarion J. Bussemakers, Gerald Verhaegh, Jack A. Schalken
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity Hospital Nijmegen
InventorsMarion J. Bussemakers, Gerald Verhaegh, Jack A. Schalken
Estimating the term…
This invention describes the cloning and characterization of the promoter region for the PCA3dd3 gene. This region regulates the PCA3dd3 gene expression by a unique prostate specific transcriptional mechanism. The present invention relates to the use of this promoter region as a tool for prostate cancer treatment and diagnosis and screening of agents which regulate expression of PCA3. In a particular embodiment, the present invention relates to an isolated promoter sequence which comprises an isolated promoter sequence which comprises a sequence as set forth between nucleotide positions 372 to 460 of SEQ ID NO:1, this sequence enabling a prostate-specific modulation of transcription.
An isolated nucleic acid comprising a sequence as set forth between nucleotide positions 372 to 460 of SEQ ID NO:1.
Dependencies are inferred from the claim text.